New Key Statistics Module, Z-Score and F-Score
NAS:PTCT Key Ratios
| Market Cap $ M | 2,471.94 |
| Enterprise Value $ M | 2,010.10 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 2.62 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 927.00 |
| EPS (TTM) $ | -7.68 |
| Beneish M-Score | -3.37 |
| 10-y EBITDA Growth Rate % | -4.70 |
| 5-y EBITDA Growth Rate % | -17.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.00 |
| EV-to-EBITDA | -7.92 |
| PEG | -- |
| Shares Outstanding M | 76.70 |
| Net Margin (%) | -62.45 |
| Operating Margin % | -30.16 |
| Pre-tax Margin (%) | -69.63 |
| Quick Ratio | 1.98 |
| Current Ratio | 2.03 |
| ROA % (ttm) | -36.70 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -24.24 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.10 |
PTCT Number of Guru Trades
PTCT Volume of Guru Trades
Gurus Latest Trades with NAS:PTCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PTCT is held by these investors
Total 2
PTC Therapeutics Inc Insider Transactions
No Available Data
News about NAS:PTCT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers